Numenor

Share this post

User's avatar
Numenor
Horizon Therapeutics: Biotechnology Company Building An Outsider Moat
Copy link
Facebook
Email
Notes
More

Horizon Therapeutics: Biotechnology Company Building An Outsider Moat

Value investing in life sciences

Numenor's avatar
Numenor
Oct 04, 2021
∙ Paid
1

Share this post

User's avatar
Numenor
Horizon Therapeutics: Biotechnology Company Building An Outsider Moat
Copy link
Facebook
Email
Notes
More
Share
  • Horizon Therapeutics is a biotechnology company focused on capital efficiency and commercialization.

  • The company has built a strong track record acquiring assets early and then efficiently bringing them to market.

  • This has led to their business model increasingly resembling Danaher or Constellation Software but focused on drug development.

  • So the investmen…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Numenor Capital
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More